Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease — Stella

Recruiting

Back to Kidney Stones trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

United States, Alabama University of Alabama at Birmingham, Birmingham, Alabama

University of Texas South Western Medical Center, Dallas, Texas

Key details

Sponsor

University of Alabama at Birmingham

Collaborators

University of Texas, Southwestern Medical Center at Dallas, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~80 participants

Started

May 2025

Primary completion

December 2030

Age range

18 Years – 80 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov